# A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy

> **NCT02296892** · PHASE3 · COMPLETED · sponsor: **Paion UK Ltd.** · enrollment: 446 (actual)

## Conditions studied

- Bronchoscopy

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Placebo
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02296892
- **Lead sponsor:** Paion UK Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-03
- **Final completion:** 2017-03-13
- **Target enrollment:** 446 (ACTUAL)
- **Last updated:** 2020-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296892, "A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02296892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*